Compare Edwards Lifesciences Corporation Common Stock (EW) vs Nucor Corporation (NUE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Nucor Corporation — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $84.25 (market cap $48.56B), while Nucor Corporation trades at $248 (market cap $55.84B). The key difference: Edwards Lifesciences Corporation Common Stock and Nucor Corporation are close in size by market cap, and Nucor Corporation pays a 0.91% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| EW | NUE | |
|---|---|---|
Market Cap | $48.56B | $55.84B |
Volume | 6,520,488 | 848,835 |
Sector | Health | Basic Materials |
52-Week High | $95.18 | $274.74 |
52-Week Low | $72.65 | $131.78 |
Enterprise Value | $45.01B | $60.25B |
Typical Hold Time | — | 78 Days |
Dividend Yield | — | 0.91% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Nucor (NUE) trades at $246.44, down 1.84% on the day, with mixed technical signals showing neutral momentum. The stock has demonstrated strong earnings performance with recent beats in Q1 and Q2 2026, though Q4 2025 missed expectations. Revenue has stabilized around $32.5B after declining from 2022 peaks, while profit margins show recovery signs. Analysts maintain a bullish stance with a $266.88 price target, representing 8% upside potential from current levels.
Nucor presents a balanced investment case with improving fundamentals but faces cyclical steel industry headwinds. The company's dividend king status and strong operational execution support long-term value, while competitive pressures and margin volatility remain key risks. Current valuation appears reasonable with P/E of 19.67 and P/S of 1.57, suggesting potential for moderate growth if steel demand strengthens.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Nucor Corporation
Nucor Corp manufactures steel and steel products. The company also produces direct reduced iron for use in its steel mills. The operations include international trading and sales companies that buy and sell steel and steel products manufactured by the company and others. The operating business segments are: steel mills, steel products and raw materials, the steel mills segment derives maximum revenue.
Read more on NUE →
